In this specialized dementia clinic cohort, we found that 3.7% of all FTD cases (including the FTD-ALS patients) and 2.7% of all clinical AD cases had a C9orf72 repeat expansion, revealing a relatively low frequency of expanded repeats in the Bulgarian dementia cohort. Here, C9orf72 is linked to Alzheimer disease.